The trademark Synapse MED was filed by SYNAPSE MEDICINE, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on May 19, 2021, and received one opposition filed on August 18, 2021 by FUJIFILM Corporation on Likelihood of confusion. the opponent was represented by BREVALEX and proceedings were handled in French, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 18, 2021
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 6, 2023. Change of name and address of the trademark registration was recorded on February 19, 2024. Relative errors of the trademark registration was recorded on September 9, 2024.
Goods And Services
The mark was filed in class 9 with following description of goods:
Artificial intelligence software relating to medical prescription
Artificial intelligence software to avoid medicinal risks, contraindications and drug interactions
Artificial intelligence software relating to prescription analysis
None of the above products are for use or provided in the field of medical informatics management and image recognition (including AI) platforms in the medical field other than for the proper use of drugs.
The mark was filed in class 42 with following description of goods:
Research in the field of artificial intelligence for designing software for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions
Research in the field of artificial intelligence for designing software for prescription analysis
Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions
Software design and development for prescription analysis
Artificial intelligence platform as software as a service [SaaS] for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions
Artificial intelligence platform as software as a service [SaaS] for prescription analysis
None of the above services are for use or provided in the field of medical informatics management and image recognition (including AI) platforms in the medical field other than for the proper use of drugs.
The mark was filed in class 44 with following description of goods:
Telemedicine services
Prescription assistance modules for telemedicine platforms
Advise relating to telemedicine
Providing information and providing news in the field of telemedicine
Providing information and providing news in the field of medical prescription
Providing information and providing news in the field of prescription analysis
None of the above services are for use or provided in the field of medical informatics management and image recognition (including AI) platforms in the medical field other than for the proper use of drugs.